Biomerieux rises on Q3 sales growth above expectations

Biomerieux SA

30/10/2024 09:06

** Shares in Biomerieux  BIOX.PA  rise 3%, after it reports
Q3 sales growth above expectations
    ** The french in-vitro diagnostic company released an 11%
organic sales growth in the third quarter compared with the 8.4%
expected in a consensus
    ** The group's growth was supported by a 17.6% growth in its
molecular biology division for the quarter thanks to sales
growth in respiratory panel, the expansion of installed base of
FilmArray and Spotfire products, Midcap  Partners analyst says
    ** The broker notes the extremely strong 9M performance is
strongly supporting the annual guidance which is based on the
assumption of a normal flu season in Q4
    ** Share is on track for its best day since September 09,
when it closed 4.5% higher
   

 (Reporting by Mathias de Rozario)
 ((mathias.derozario@thomsonreuters.com))